What Is All the Hype About Semaglutide?
Fad diets come and go, and every few years there’s a trending weight loss pill that everyone is talking about. Since 80% of diets fail and there’s always a “next” weight loss pill, you aren’t alone if you aren’t paying too much attention to all the buzz surrounding Semaglutide. But we’re over a year into…

Fad diets come and go, and every few years there’s a trending weight loss pill that everyone is talking about. Since 80% of diets fail and there’s always a “next” weight loss pill, you aren’t alone if you aren’t paying too much attention to all the buzz surrounding Semaglutide. But we’re over a year into the hype, so it’s time to take notice.
This new weight loss prescription is so in-demand that Novo Nordisk, the Danish pharmaceutical company that produces it, has had to transition to 24/7 production. They are also in the process of building two more production labs to keep up with demand.
Why is the demand so high? Semaglutide is being hailed as Hollywood’s weight loss secret. Billionaire Elon Musk attributes his trimmer physique to Semaglutide, Dr. Oz has highlighted it on his show, and it’s suspected (but not confirmed) that it’s a Kardashian go-to.
Celebrities aside, weight loss is sustainable, and the side effects are minimal. Here’s what you need to know.
What is Semaglutide?
Semaglutide is the generic name and primary active ingredient in the brand name prescription medications Rybelsus, Ozempic, and Wegovy made by pharmaceutical company Novo Nordisk. Combating diabetes is one of Novo Nordisk’s core objectives. In 2017, their daily pill Rybelsus was FDA-approved for Type 2 diabetes, followed by the Type 2 diabetic injection Ozempic. It performs by mimicking the hormones produced in the gut called GLP-1 which regulates insulin and blood sugar levels. GLP-1 has far-reaching benefits, including reducing inflammation and the risk of cardiovascular disease.
Rybelsus and Ozempic patients quickly displayed a few other positive side effects, including feeling fuller longer and fewer food cravings. In other words, no more “seconds” and fewer between-meal snacks. This prompted the 2021 FDA approval and…
Read full article Source